Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Xyratex (XRTX) Competitors

Xyratex logo

XRTX vs. ABVC, TXMD, IMNN, MRKR, SYBX, LSB, RLMD, QNTM, PHIO, and NERV

Should you be buying Xyratex stock or one of its competitors? The main competitors of Xyratex include ABVC BioPharma (ABVC), TherapeuticsMD (TXMD), Imunon (IMNN), Marker Therapeutics (MRKR), Synlogic (SYBX), Lakeshore Biopharma (LSB), Relmada Therapeutics (RLMD), Quantum Biopharma (QNTM), Phio Pharmaceuticals (PHIO), and Minerva Neurosciences (NERV). These companies are all part of the "pharmaceutical preparations" industry.

Xyratex vs.

ABVC BioPharma (NASDAQ:ABVC) and Xyratex (NASDAQ:XRTX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, community ranking, analyst recommendations, earnings and valuation.

Xyratex has a net margin of 0.00% compared to ABVC BioPharma's net margin of -1,619.65%. ABVC BioPharma's return on equity of -104.94% beat Xyratex's return on equity.

Company Net Margins Return on Equity Return on Assets
ABVC BioPharma-1,619.65% -104.94% -56.81%
Xyratex N/A -146.27%-86.83%

Xyratex received 156 more outperform votes than ABVC BioPharma when rated by MarketBeat users.

CompanyUnderperformOutperform
ABVC BioPharmaN/AN/A
XyratexOutperform Votes
156
63.41%
Underperform Votes
90
36.59%

11.4% of ABVC BioPharma shares are held by institutional investors. Comparatively, 0.2% of Xyratex shares are held by institutional investors. 11.9% of ABVC BioPharma shares are held by company insiders. Comparatively, 6.9% of Xyratex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Xyratex has lower revenue, but higher earnings than ABVC BioPharma. ABVC BioPharma is trading at a lower price-to-earnings ratio than Xyratex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ABVC BioPharma$509.59K32.82-$10.52M-$0.47-2.26
XyratexN/AN/A-$2.16M-$1.35-0.76

In the previous week, ABVC BioPharma had 1 more articles in the media than Xyratex. MarketBeat recorded 2 mentions for ABVC BioPharma and 1 mentions for Xyratex. ABVC BioPharma's average media sentiment score of 0.46 beat Xyratex's score of 0.00 indicating that ABVC BioPharma is being referred to more favorably in the media.

Company Overall Sentiment
ABVC BioPharma Neutral
Xyratex Neutral

ABVC BioPharma has a beta of 0.33, suggesting that its stock price is 67% less volatile than the S&P 500. Comparatively, Xyratex has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500.

Summary

ABVC BioPharma beats Xyratex on 8 of the 13 factors compared between the two stocks.

Get Xyratex News Delivered to You Automatically

Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XRTX vs. The Competition

MetricXyratexPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$3.87M$6.89B$5.56B$7.82B
Dividend YieldN/A3.05%5.11%4.22%
P/E Ratio-0.767.4422.5118.48
Price / SalesN/A242.70395.68103.60
Price / CashN/A65.8538.1834.62
Price / Book0.446.516.774.25
Net Income-$2.16M$143.21M$3.22B$248.23M

Xyratex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XRTX
Xyratex
0.5626 of 5 stars
$1.02
-0.5%
N/A-59.8%$3.87MN/A-0.76N/AHigh Trading Volume
ABVC
ABVC BioPharma
1.0933 of 5 stars
$0.83
-4.7%
N/A-15.2%$13.12M$509,788.00-0.9730Earnings Report
TXMD
TherapeuticsMD
1.77 of 5 stars
$1.11
+11.4%
N/A-34.0%$12.85M$1.76M0.00420Analyst Forecast
Gap Down
IMNN
Imunon
2.7241 of 5 stars
$0.87
-1.9%
$21.50
+2,365.6%
-35.9%$12.75M$500,000.00-0.4630Short Interest ↓
MRKR
Marker Therapeutics
4.5534 of 5 stars
$1.19
-0.8%
$13.17
+1,006.4%
-70.6%$12.74M$6.59M-0.9960Short Interest ↓
Positive News
SYBX
Synlogic
2.4441 of 5 stars
$1.09
+2.7%
N/A-36.3%$12.74M$8,000.00-0.2680Short Interest ↓
Positive News
Gap Down
LSB
Lakeshore Biopharma
1.3978 of 5 stars
$1.36
+5.9%
N/AN/A$12.61M$672.27M0.00773Short Interest ↓
Positive News
RLMD
Relmada Therapeutics
4.2749 of 5 stars
$0.38
+17.0%
$4.25
+1,024.3%
-91.1%$12.55MN/A-0.1310Upcoming Earnings
Gap Down
High Trading Volume
QNTM
Quantum Biopharma
N/A$6.28
+0.6%
N/AN/A$12.05MN/A-0.41N/AUpcoming Earnings
Gap Down
PHIO
Phio Pharmaceuticals
2.5269 of 5 stars
$2.51
-11.3%
$4.00
+59.4%
-69.4%$11.99MN/A-0.2310Upcoming Earnings
Gap Down
NERV
Minerva Neurosciences
3.6794 of 5 stars
$1.71
+3.0%
$5.00
+192.4%
-29.2%$11.96MN/A-3.899Negative News

Related Companies and Tools


This page (NASDAQ:XRTX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners